GAMMA Investing’s Avita Medical RCEL Stock Holding History

GAMMA Investing’s Portfolio RCEL Stock Details RCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.23K	Hold	190	–	–	﹤0.01%	3921
2026 Q2	$785	Sell	190 -982	-84%	-$4.24K	﹤0.01%	3924
2026 Q1	$4.34K	Buy	1,172 +1,105	+1,649%	+$4.64K	﹤0.01%	3412
2025 Q4	$231	Sell	67 -310	-82%	-$1.24K	﹤0.01%	3988
2025 Q3	$1.93K	Buy	377 +85	+29%	+$444	﹤0.01%	3457
2025 Q2	$1.54K	Sell	292 -491	-63%	-$3.57K	﹤0.01%	3454
2025 Q1	$6.37K	Sell	783 -25	-3%	-$234	﹤0.01%	2973
2024 Q4	$10.3K	Buy	808 +559	+224%	+$6.59K	﹤0.01%	2601
2024 Q3	$2.67K	Buy	249 +175	+236%	+$1.64K	﹤0.01%	2974
2024 Q2	$586	Sell	74 -5	-6%	-$48	﹤0.01%	3178
2024 Q1	$1.27K	Buy	79 +62	+365%	+$1K	﹤0.01%	2888
2023 Q4	$285	Buy	+17	New	+$195	﹤0.01%	3077

Other funds holding RCEL

HCA

Harpswell Capital Advisors Yarmouth, Maine $152M AUM 8.39% 1-Year Est. Return

GAMMA Investing's RCEL Position: Q3 2026 in Review

GAMMA Investing held its Avita Medical (RCEL) position steady in Q3 2026 at 190 shares worth $2.23K. The position accounts for ﹤0.01% of the portfolio, ranked #3921.

GAMMA Investing first reported a position in RCEL in Q4 2023 and has held it in 12 quarters since. The position peaked at $10.3K in Q4 2024. 2 funds tracked by Wall St. Rank hold RCEL as of Q3 2026.

GAMMA Investing held 190 shares of Avita Medical worth $2.23K as of Q3 2026.
GAMMA Investing left its Avita Medical share count unchanged in Q3 2026.
Avita Medical made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3921 holding.
GAMMA Investing first reported a position in Avita Medical in Q4 2023 and has held it in 12 quarters since.
GAMMA Investing's Avita Medical position peaked at $10.3K in Q4 2024.
2 funds tracked by Wall St. Rank held Avita Medical as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.